Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Galphimia glauca 6ch: Oral route of administration pill form 30 number pill size centesimal scale first dose after case taking subsequent doses after each follow up and potency accordin
Sponsors
Bakson homoeopathic medical college and hospital
Eligibility
Inclusion criteria
Inclusion criteria: Participants clinically diagnosed with allergic rhinitis of age group 6-18 years, irrespective of their religion and gender Participants with score less than 25 on ARSS scale Participants willing to give assent for the study
Exclusion criteria
Exclusion criteria: Participants with severe systemic illness, any immuno-compromised condition, any psychiatric issues, under any substance abuse and severe endocrine disorders Gross nasal developmental defects or structural abnormalities causing obstruction, e.g., nasal polyp(s), deviated septum Participants on any sort of treatment in last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in Allergic rhinitis symptom score (ARSS) will signify improvement in signs and symptoms of allergic rhinitisTimepoint: Allergic rhinitis symptom score (ARSS) will be evaluated at baseline, 4th week,8th week till 24 week. Study duration 15 months Enrollment period (6 months) Follow up duration (6 months) Data analysis and report writing (3 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Puneet Garg
Bakson Homoeopathic Medical College And Hospital
Outcome results
None listed